Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

J-2156 TFA

😃Good
Catalog No. T64113Cas No. 2387505-73-7
Alias J2156 TFA, J 2156 TFA

J-2156 TFA is a selective SST4 receptor (somatostatin receptor type 4) agonist with IC50 values of 0.05 nM and 0.07 nM for human and rat SST4 receptors respectively. It exhibits anti-inflammatory and analgesic effects while reducing pERK levels.

J-2156 TFA

J-2156 TFA

😃Good
Catalog No. T64113Alias J2156 TFA, J 2156 TFACas No. 2387505-73-7
J-2156 TFA is a selective SST4 receptor (somatostatin receptor type 4) agonist with IC50 values of 0.05 nM and 0.07 nM for human and rat SST4 receptors respectively. It exhibits anti-inflammatory and analgesic effects while reducing pERK levels.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$64-In Stock
5 mgPreferential-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
J-2156 TFA is a selective SST4 receptor (somatostatin receptor type 4) agonist with IC50 values of 0.05 nM and 0.07 nM for human and rat SST4 receptors respectively. It exhibits anti-inflammatory and analgesic effects while reducing pERK levels.
Targets&IC50
SST4 (human):0.05 nM, SST4 (rat):0.07 nM
In vitro
J-2156 TFA exhibits nanomolar affinity (Ki=1.2 nM) for the homo sapiens somatostatin receptor subtype 4 (hsst4), with over 400-fold selectivity for this subtype compared to other somatostatin receptors [2].
In vivo
J-2156 TFA (1-10 mg/kg, 3 hours) was administered as a single intraperitoneal injection, which produced anti-parazacco spilurus subsp. spilurus chronic pain effects in both ipsilateral and contralateral sides of BCIBP rats [1].
SynonymsJ2156 TFA, J 2156 TFA
Chemical Properties
Molecular Weight582.6
FormulaC26H29F3N4O6S
Cas No.2387505-73-7
SmilesOC(=O)C(F)(F)F.Cc1ccc(c2ccccc12)S(=O)(=O)N[C@@H](CCN)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
Storage & Solubility Information
Storagekeep away from moisture,keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
H2O: 80 mg/mL (137.32 mM), Sonication is recommended.
DMSO: 80 mg/mL (137.32 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween-80+45% Saline: 3.3 mg/mL (5.66 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
H2O/DMSO
1mg5mg10mg50mg
1 mM1.7164 mL8.5822 mL17.1644 mL85.8222 mL
5 mM0.3433 mL1.7164 mL3.4329 mL17.1644 mL
10 mM0.1716 mL0.8582 mL1.7164 mL8.5822 mL
20 mM0.0858 mL0.4291 mL0.8582 mL4.2911 mL
50 mM0.0343 mL0.1716 mL0.3433 mL1.7164 mL
100 mM0.0172 mL0.0858 mL0.1716 mL0.8582 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy J-2156 TFA | purchase J-2156 TFA | J-2156 TFA cost | order J-2156 TFA | J-2156 TFA chemical structure | J-2156 TFA in vivo | J-2156 TFA in vitro | J-2156 TFA formula | J-2156 TFA molecular weight